Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Chief Executive Officer at FDNA
As the founding CEO of FDNA, Mr. Dekel Gelbman leads the corporate and business strategy of the company that turned an early stage computer vision technology into an innovative digital health platform and database used by thousands of clinicians, researchers and labs globally in the evaluation of genetic and other rare disease patients. Before joining FDNA, Mr. Gelbman was a practicing attorney, working for leading law firms, including among others, Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates. Working closely with dozens of start-up companies for over a decade, including innovative technological companies from a wide variety of fields, Mr. Gelbman brings extensive experience in business development, legal counseling, and regulatory compliance to his role. Mr. Gelbman holds an LL.B and an MBA in finance.